Bhooshi de Silva serves as senior vice president of corporate development and strategy for PPD. He joined PPD in 2014 in that role, in which he serves as a member of PPD’s executive leadership team, leading the strategy, corporate development (M&A, partnerships), enterprise data and innovation functions. De Silva partners with the senior leadership team on key strategic initiatives, leads PPD’s data and disruptive innovation priorities, and plays an important role in driving the company’s evolution and growth. Since joining PPD, de Silva has led the organization in completing several strategic partnerships and acquisitions, and in strengthening and expanding the company’s capabilities in priority focus areas.
Prior to PPD, de Silva spent 15 years in the biopharmaceutical industry, where he held several leadership positions. He started his career at Pfizer, where his roles spanned R&D portfolio management, U.S. commercial development, and U.S. customer strategy and negotiations. In 2009, de Silva was named vice president of business development evaluation and strategy, leading a team in the evaluation of licensing, acquisitions and corporate strategic initiatives for Pfizer. Later, he was head of corporate development, corporate strategy and head of international at Optimer Pharmaceuticals. De Silva played an integral role in the commercialization strategy and Optimer’s sale to Cubist Pharmaceuticals in 2013. He has an impressive track record of achievement in corporate strategic initiatives and M&A transactions on both the buy and sell sides.
De Silva holds degrees in finance, economics and engineering from Stanford University, London School of Economics and Imperial College of Science & Technology in London.